Treatment & Outcomes of Stage III Colon Cancer in Patients 80 Years of Age

Clinical Trial Description

This retrospective population-based study included patients aged 80 years and older with stage III colon adenocarcinoma who underwent surgery between 2007 and 2014. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT04003181` - The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon	N/A
Active, not recruiting	`NCT04057274` - Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth	N/A
Completed	`NCT02127359` - Whole-Exome Sequencing (WES) of Cancer Patients
Completed	`NCT00096278` - Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer	Phase 3
Active, not recruiting	`NCT02912559` - Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair	Phase 3
Completed	`NCT02569723` - Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy	N/A
Recruiting	`NCT05746195` - Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)	N/A
Active, not recruiting	`NCT03365882` - S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery	Phase 2
Completed	`NCT02393755` - Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer	Phase 1/Phase 2
Recruiting	`NCT05710406` - Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer	Phase 2/Phase 3
Recruiting	`NCT06017141` - Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study	Phase 2
Active, not recruiting	`NCT03436563` - M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability	Phase 1/Phase 2
Recruiting	`NCT05482516` - Evaluating Novel Therapies in ctDNA Positive GI Cancers	Phase 3
Completed	`NCT02368886` - Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer	Phase 2
Active, not recruiting	`NCT02863107` - Young-Onset Colorectal Cancer
Active, not recruiting	`NCT04963283` - Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer	Phase 2
Recruiting	`NCT06414304` - Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy
Completed	`NCT05872334` - The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery	N/A
Not yet recruiting	`NCT06426927` - PeLear CCC: Proyecto Latino Contra Cancer Colorectal	N/A
Completed	`NCT03949777` - Validation of Aer-O-Scope Colonoscope System Cecal Intubation	N/A

NCT number	NCT04526314
Study type	Observational
Source	Registre des Tumeurs Digestives du Finistère
Contact
Status	Completed
Phase
Start date	January 1, 2018
Completion date	July 1, 2020

Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms